Hydrocodone Bitartrate and Acetaminophen
INDICATIONS AND USAGE Hydrocodone Bitartrate and Acetaminophen Tablet is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, which can occur at dosage or duration [see WARNINGS ], reserve Hydrocodone Bitartrate and Acetaminophen Tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] have not been tolerated, or are not expected to be tolerated, have not provided adequate analgesia, or are not expected to provide adequate analgesia Hydrocodone Bitartrate and Acetaminophen Tablets should not be used for an extended period of time unless the pain remains severe enough to require an opioid analgesic and for which alternative treatment options continue to be inadequate.
eywa pharma inc
OVAL WHITE WES 302
WES 302 OVAL WHITE
Related Pills
hydrocodone bitartrate and acetaminophen tablet
eywa pharma inc
hydrocodone bitartrate and acetaminophen tablet
eywa pharma inc
Acetaminophen 325 MG Hydrocodone Bitartrate 5 MG Oral Tablet
Eywa Pharma Inc
hydrocodone bitartrate and acetaminophen tablet
eywa pharma inc
Acetaminophen 325 MG Hydrocodone Bitartrate 5 MG Oral Tablet
Eywa Pharma Inc
hydrocodone bitartrate and acetaminophen tablet
eywa pharma inc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
HYDROCODONE BITARTRATE AND ACETAMINOPHEN Tablets, USP are supplied as:
HYDROCODONE BITARTRATE AND ACETAMINOPHEN Tablets USP, 5/325 peach colored capsule shaped tablets, one side scored and other side debossed with “WES 301”. Each tablet contains 5 mg hydrocodone bitartrate and 325 mg acetaminophen. They are supplied in bottles of 100 (NDC 71930-019-12) 500 (NDC 71930-019-52) and 1000 (NDC 71930-019-13).
HYDROCODONE BITARTRATE AND ACETAMINOPHEN Tablets USP, 7.5/325 white colored capsule shaped tablets, one side scored and other side debossed with “WES 302”. Each tablet contains 7.5 mg hydrocodone bitartrate and 325 mg acetaminophen. They are supplied in bottles of 100 (NDC 71930-020-12) 500 (NDC 71930-020-52) and 1000 (NDC 71930-020-13).
HYDROCODONE BITARTRATE AND ACETAMINOPHEN Tablets USP, 10/325 blue colored capsule shaped tablets, one side scored and other side debossed with “WES 303”. Each tablet contains 10 mg hydrocodone bitartrate and 325 mg acetaminophen. They are supplied in bottles of 100 (NDC 71930-021-12) 500 (NDC 71930-021-52) and 1000 (NDC 71930-021-13). Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Store
HYDROCODONE BITARTRATE AND ACETAMINOPHEN Tablets, USP securely and dispose of properly [see PRECAUTIONS / Information for Patients ]. Manufactured by: WES Pharma Inc Westminster, MD 21157 USA Distributed by: Eywa Pharma Inc 2 Research Way, Floor 3 Princeton, NJ 08540 Revised: 01/2024
More pills like OVAL WES 302